CardioComm Solutions (EKG.V) Stock Price

CardioComm Solutions Price

OTC·CLOSED
0.01CAD+0.00 (+0.00 %)
Market closed

Revenue at CardioComm Solutions has contracted by 3.4% per year over the past 19 years to 526,700.00 CAD. CardioComm Solutions's net margin stands at -36.9%, down from -7.6% several years earlier. The stock trades about 102,300% above its 52-week low.

CardioComm Solutions stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of CardioComm Solutions over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CardioComm Solutions stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CardioComm Solutions's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CardioComm Solutions Stock Price History
DateCardioComm Solutions Price
7/23/20260.01 CAD
7/22/20260.01 CAD
7/21/20260.01 CAD
7/20/20260.01 CAD
7/17/20260.01 CAD
7/16/20260.01 CAD
7/15/20260.01 CAD
7/14/20260.01 CAD
7/13/20260.01 CAD
7/10/20260.01 CAD
7/9/20260.01 CAD
7/8/20260.01 CAD
7/7/20260.01 CAD
7/6/20260.01 CAD
7/3/20260.01 CAD
7/2/20260.00 CAD
6/30/20260.00 CAD
6/29/20260.00 CAD
6/26/20260.00 CAD
6/25/20260.00 CAD
6/24/20260.00 CAD
6/23/20260.00 CAD
6/22/20260.00 CAD
6/19/20260.00 CAD
6/17/20260.00 CAD
6/16/20260.00 CAD
6/15/20260.00 CAD
6/12/20260.00 CAD
6/11/20260.00 CAD
6/10/20260.00 CAD
6/9/20260.00 CAD
6/8/20260.00 CAD
6/5/20260.00 CAD
6/4/20260.00 CAD
6/3/20260.00 CAD
6/2/20260.00 CAD
6/1/20260.00 CAD
5/29/20260.00 CAD
5/28/20260.00 CAD
5/27/20260.00 CAD
5/26/20260.00 CAD
5/25/20260.00 CAD
5/22/20260.00 CAD
5/21/20260.00 CAD
5/20/20260.00 CAD
5/19/20260.00 CAD
5/15/20260.00 CAD
5/14/20260.00 CAD
5/13/20260.00 CAD
5/12/20260.00 CAD
5/11/20260.00 CAD
5/8/20260.00 CAD
5/7/20260.00 CAD
5/6/20260.00 CAD
5/5/20260.00 CAD
5/4/20260.00 CAD
5/1/20260.00 CAD
4/30/20260.00 CAD
4/29/20260.00 CAD
4/28/20260.00 CAD
4/27/20260.00 CAD
4/24/20260.00 CAD
4/23/20260.00 CAD
4/22/20260.00 CAD
4/21/20260.00 CAD
4/20/20260.00 CAD
4/17/20260.00 CAD
4/16/20260.00 CAD
4/15/20260.00 CAD
4/14/20260.00 CAD
4/13/20260.00 CAD
4/10/20260.00 CAD
4/9/20260.00 CAD
4/8/20260.00 CAD
4/7/20260.00 CAD
4/6/20260.00 CAD
4/2/20260.00 CAD
4/1/20260.00 CAD
3/31/20260.00 CAD
3/30/20260.00 CAD
3/27/20260.00 CAD
3/26/20260.00 CAD
3/25/20260.00 CAD
3/24/20260.00 CAD
3/23/20260.00 CAD
3/20/20260.00 CAD
3/19/20260.00 CAD
3/18/20260.00 CAD
3/17/20260.00 CAD
3/16/20260.00 CAD
3/13/20260.00 CAD
3/12/20260.00 CAD
3/11/20260.00 CAD
3/10/20260.00 CAD
3/9/20260.00 CAD
3/6/20260.00 CAD
3/5/20260.00 CAD
3/4/20260.00 CAD
3/3/20260.00 CAD
3/2/20260.00 CAD
2/27/20260.00 CAD
2/26/20260.00 CAD
2/25/20260.00 CAD
2/24/20260.00 CAD
2/23/20260.00 CAD
2/20/20260.00 CAD
2/19/20260.00 CAD
2/18/20260.00 CAD
2/17/20260.00 CAD
2/13/20260.00 CAD
2/12/20260.00 CAD
2/11/20260.00 CAD
2/10/20260.00 CAD
2/9/20260.00 CAD
2/6/20260.00 CAD
2/5/20260.00 CAD
2/4/20260.00 CAD
2/3/20260.00 CAD
2/2/20260.00 CAD
1/30/20260.00 CAD
1/29/20260.00 CAD
1/28/20260.00 CAD
1/27/20260.00 CAD
1/26/20260.00 CAD
1/23/20260.00 CAD
1/22/20260.00 CAD
1/21/20260.00 CAD
1/20/20260.00 CAD
1/19/20260.00 CAD
1/16/20260.00 CAD
1/15/20260.00 CAD
1/14/20260.00 CAD
1/13/20260.00 CAD
1/12/20260.00 CAD
1/9/20260.00 CAD
1/8/20260.00 CAD
1/7/20260.00 CAD
1/6/20260.00 CAD
1/5/20260.00 CAD
1/2/20260.00 CAD
12/31/20250.00 CAD
12/30/20250.00 CAD
12/29/20250.00 CAD
12/24/20250.00 CAD
12/23/20250.00 CAD
12/22/20250.00 CAD
12/19/20250.00 CAD
12/18/20250.00 CAD
12/17/20250.00 CAD
12/16/20250.00 CAD
12/15/20250.00 CAD
12/12/20250.00 CAD
12/11/20250.00 CAD
12/10/20250.00 CAD
12/9/20250.00 CAD
12/8/20250.00 CAD
12/5/20250.00 CAD
12/4/20250.00 CAD
12/3/20250.00 CAD
12/2/20250.00 CAD
12/1/20250.00 CAD
11/28/20250.00 CAD
11/27/20250.00 CAD
11/26/20250.00 CAD
11/25/20250.00 CAD
11/24/20250.00 CAD
11/21/20250.00 CAD
11/20/20250.00 CAD
11/19/20250.00 CAD
11/18/20250.00 CAD
11/17/20250.00 CAD
11/14/20250.00 CAD
11/13/20250.00 CAD
11/12/20250.00 CAD
11/11/20250.00 CAD
11/10/20250.00 CAD
11/7/20250.00 CAD
11/6/20250.00 CAD
11/5/20250.00 CAD
11/4/20250.00 CAD
11/3/20250.00 CAD
10/31/20250.00 CAD
10/30/20250.00 CAD
10/29/20250.00 CAD
10/28/20250.00 CAD
10/27/20250.00 CAD
10/24/20250.00 CAD
10/23/20250.00 CAD
10/22/20250.00 CAD
10/21/20250.00 CAD
10/20/20250.00 CAD
10/17/20250.00 CAD
10/16/20250.00 CAD
10/15/20250.00 CAD
10/14/20250.00 CAD
10/10/20250.00 CAD
10/9/20250.00 CAD
10/8/20250.00 CAD
10/7/20250.00 CAD
10/6/20250.00 CAD
10/3/20250.00 CAD
10/2/20250.00 CAD
10/1/20250.00 CAD
9/30/20250.00 CAD
9/29/20250.00 CAD
9/26/20250.00 CAD
9/25/20250.00 CAD
9/24/20250.00 CAD
9/23/20250.00 CAD
9/22/20250.00 CAD
9/19/20250.00 CAD
9/18/20250.00 CAD
9/17/20250.00 CAD
9/16/20250.00 CAD
9/15/20250.00 CAD
9/12/20250.00 CAD
9/11/20250.00 CAD
9/10/20250.00 CAD
9/9/20250.00 CAD
9/8/20250.00 CAD
9/5/20250.00 CAD
9/4/20250.00 CAD
9/3/20250.00 CAD
9/2/20250.00 CAD
8/29/20250.00 CAD
8/28/20250.00 CAD
8/27/20250.00 CAD
8/26/20250.00 CAD
8/25/20250.00 CAD
8/22/20250.00 CAD
8/21/20250.00 CAD
8/20/20250.00 CAD
8/19/20250.00 CAD
8/18/20250.00 CAD
8/15/20250.00 CAD
8/14/20250.00 CAD
8/13/20250.00 CAD
8/12/20250.00 CAD
8/11/20250.00 CAD
8/8/20250.00 CAD
8/7/20250.00 CAD
8/6/20250.00 CAD
8/5/20250.00 CAD
8/1/20250.00 CAD
7/31/20250.00 CAD
7/30/20250.00 CAD
7/29/20250.00 CAD
7/28/20250.00 CAD
7/25/20250.00 CAD
Access this data via the Eulerpool API
Get Free API Key

CardioComm Solutions Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
1.74 M CAD
161,700.00 CAD
39,600.00 CAD
Jan 1, 2018
1.08 M CAD
-543,700.00 CAD
-577,100.00 CAD
Jan 1, 2019
874,900.00 CAD
-864,800.00 CAD
-1.06 M CAD
Jan 1, 2020
834,800.00 CAD
-77,900.00 CAD
-63,600.00 CAD
Jan 1, 2021
682,500.00 CAD
-211,900.00 CAD
300.00 CAD
Jan 1, 2022
995,800.00 CAD
-77,400.00 CAD
-2,500.00 CAD
Jan 1, 2023
876,400.00 CAD
-207,500.00 CAD
-97,300.00 CAD
Jan 1, 2024
526,700.00 CAD
-291,100.00 CAD
-194,600.00 CAD

CardioComm Solutions Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 7:14 PM
 
REVENUEM CAD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEk CAD
EBITM CAD
EBIT MARGIN%
NET INCOMEM CAD
NET INCOME GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
1.001.002.001.001.001.001.001.001.001.00––––––
––100.00-50.00––––––––––––
100.00100.0050.00100.00100.00100.00100.00100.00100.00100.00––––––
1,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.001,000.00
-1.00––-3.00-1.00–––––––––––
-100.00––-300.00-100.00–––––––––––
-1.00––-3.00-1.00–––––-1.00–––––
––––-66.67–––––––––––
45.7460.1375.6591.66100.26106.77112.16115.86135.04137.22139.52141.44149.15150.82151.15171.20
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CardioComm Solutions generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CardioComm Solutions retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CardioComm Solutions's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CardioComm Solutions has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CardioComm Solutions's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CardioComm Solutions stock margins

The CardioComm Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CardioComm Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CardioComm Solutions.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
83.87 %
9.29 %
2.28 %
Jan 1, 2018
63.84 %
-50.55 %
-53.65 %
Jan 1, 2019
71.69 %
-98.85 %
-121.40 %
Jan 1, 2020
81.71 %
-9.33 %
-7.62 %
Jan 1, 2021
89.51 %
-31.05 %
0.04 %
Jan 1, 2022
73.06 %
-7.77 %
-0.25 %
Jan 1, 2023
84.14 %
-23.68 %
-11.10 %
Jan 1, 2024
95.04 %
-55.27 %
-36.95 %

CardioComm Solutions Stock Revenue, EBIT, Earnings per Share

The CardioComm Solutions earnings per share therefore indicates how much revenue CardioComm Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.01 CAD
0.00 CAD
0.00 CAD
Jan 1, 2018
0.01 CAD
-0.00 CAD
-0.00 CAD
Jan 1, 2019
0.01 CAD
-0.01 CAD
-0.01 CAD
Jan 1, 2020
0.01 CAD
-0.00 CAD
-0.00 CAD
Jan 1, 2021
0.00 CAD
-0.00 CAD
0.00 CAD
Jan 1, 2022
0.01 CAD
-0.00 CAD
-0.00 CAD
Jan 1, 2023
0.01 CAD
-0.00 CAD
-0.00 CAD
Jan 1, 2024
0.00 CAD
-0.00 CAD
-0.00 CAD

CardioComm Solutions business model & stock analysis

CardioComm Solutions Inc is a Canadian company specialized in the development and marketing of monitoring and management solutions for EKG data. The company offers innovative products and services aimed at improving the efficiency and quality of EKG monitoring. History: CardioComm Solutions Inc was founded in 1994 by Etienne Grima in Toronto. Since its establishment, the company has developed a variety of products and services that provide easy and effective access to EKG data. Over the years, CardioComm Solutions Inc has received several awards, including the Innovations Award from Canadian Healthcare Technology in 2008. Business model: CardioComm Solutions Inc's business model includes the development and marketing of EKG monitoring solutions for various markets. The company offers products and services for hospitals, clinics, medical facilities, and other healthcare providers. It also provides solutions for consumer and fitness markets. The company has built an extensive network of partners in North America, Europe, and Asia to provide its customers worldwide with quick and easy access to its products and services. Divisions: CardioComm Solutions Inc offers various divisions. An important focus is on the development of EKG monitoring systems for hospitals and medical facilities. These solutions are aimed at improving workflow and patient monitoring efficiency. Another important area is telemedicine. The company offers solutions that allow patients to monitor their EKG data from home and share it with their doctors. This enables more effective monitoring of patients with heart problems, especially in regions with limited access to medical care. In addition, the company also offers solutions for consumer and fitness markets. One of the company's best-known brands is KardiaMobile. KardiaMobile is a portable EKG device held in the hand and connected to a smartphone app that allows for quick and accurate heart rhythm monitoring. The company has also developed a similar device called KardiaBand, which is worn in the form of a wristband. Products: CardioComm Solutions Inc's products include a variety of EKG monitoring solutions tailored to the needs of different markets. One of the well-known solutions is the Global EKG Management System (GEMS). GEMS is a web-based solution that enables reception, display, and access to EKG data from various locations. The company also offers mobile solutions, including KardiaMobile and KardiaBand, as well as solutions for clinical studies and research projects. Additionally, the company provides training and support for its products and services. Conclusion: CardioComm Solutions Inc is an innovative company that offers a wide range of EKG monitoring and management solutions for various markets. The company has built a reputation for quality and reliability and has a strong presence in the global market. With its advanced technology and dedicated professionals, CardioComm Solutions Inc is well-positioned to achieve further growth and success in the coming years.

CardioComm Solutions SWOT Analysis

Strengths

CardioComm Solutions Inc has several strengths that contribute to its success in the market. These include:

  • Strong product line: CardioComm offers a range of innovative and reliable healthcare solutions.
  • Market leadership: The company has established itself as a leader in the electrocardiogram (ECG) management market.
  • Advanced technology: CardioComm's solutions leverage cutting-edge technology, ensuring accuracy and efficiency.
  • Strong customer base: The company has built a loyal customer base, including healthcare providers and institutions.
  • Experienced management team: CardioComm is led by a team of industry experts with extensive knowledge and experience.

Weaknesses

Despite its strengths, CardioComm Solutions Inc also faces certain weaknesses that it needs to address. These weaknesses include:

  • Limited market presence: The company may face challenges in expanding its market reach and penetrating new regions.
  • Dependence on key customers: CardioComm relies heavily on a few major customers, which poses a risk to its revenue stream.
  • High product costs: The advanced technology used in CardioComm's solutions may make them expensive for some potential customers.

Opportunities

CardioComm Solutions Inc can capitalize on several opportunities to further grow and enhance its market position. These opportunities include:

  • Expanding into new markets: The company can explore untapped markets and expand its customer base globally.
  • Partnerships and collaborations: CardioComm can establish strategic partnerships with healthcare institutions to accelerate adoption of its solutions.
  • Advancements in telemedicine: The growing trend of telemedicine presents an opportunity for CardioComm to offer remote heart monitoring solutions.
  • Increasing healthcare awareness: The increasing focus on preventive healthcare creates a demand for advanced cardiac monitoring solutions.

Threats

Despite the opportunities, CardioComm Solutions Inc also faces certain threats that could potentially hinder its growth. These threats include:

  • Intense competition: The market for ECG management solutions is highly competitive, with several established players.
  • Regulatory challenges: Changing regulations and compliance requirements can pose challenges for CardioComm's products and services.
  • Technological advancements: Rapid advancements in technology may render CardioComm's existing solutions obsolete if not adapted timely.
  • Economic downturn: A recession or economic downturn can lead to reduced healthcare spending, impacting CardioComm's sales.

CardioComm Solutions Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CardioComm Solutions historical P/E ratio, EBIT multiple, and P/S ratio

CardioComm Solutions annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CardioComm Solutions shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
135.04 M Stocks
Jan 1, 2018
137.22 M Stocks
Jan 1, 2019
139.52 M Stocks
Jan 1, 2020
141.44 M Stocks
Jan 1, 2021
149.15 M Stocks
Jan 1, 2022
150.82 M Stocks
Jan 1, 2023
151.15 M Stocks
Jan 1, 2024
171.20 M Stocks

CardioComm Solutions stock splits

In CardioComm Solutions's history, there have been no stock splits.
Price targets and forecasts for CardioComm Solutions are not yet available.

CardioComm Solutions shareholder structure

% Name
22.67609%
Langer (Anatoly)
Langer (Anatoly)
22.11540%
Grima (Daniel)
Grima (Daniel)
8.50242%
Grima (Etienne)
Grima (Etienne)
1.08048%
Caines (Robert Earle)
Caines (Robert Earle)
0.38551%
Black (Robin)
Black (Robin)

CardioComm Solutions Executives and Management Board

EG

Mr. Etienne Grima

Chief Executive Officer, Corporate Secretary, Director · since 2006

Compensation190,487.00 CAD
JB

Ms. Josee Bertrand

Chief Financial Officer

Compensation15,255.00 CAD
RC

Mr. Robert Caines

Independent Chairman of the Board

Compensation9,700.00 CAD
SB

Mr. Steven Benyo

Independent Director

Compensation7,200.00 CAD
JF

Dr. John Foote

Independent Director

Compensation5,200.00 CAD

Frequently asked questions about CardioComm Solutions

The business model of CardioComm Solutions Inc focuses on providing innovative, web-based telemedicine and patient monitoring solutions. With a strong emphasis on cardiac healthcare, the company offers a range of software tools and services that enable remote monitoring, analysis, and reporting of heart-related medical data. By leveraging advanced technology and expertise in electrocardiography (ECG), CardioComm Solutions aims to enhance patient care, streamline workflow efficiency, and facilitate better communication between healthcare professionals, patients, and caregivers. The company continues to develop and optimize its solutions to meet the evolving needs of the healthcare industry, promoting improved outcomes and increased accessibility to cardiac diagnostics and monitoring.

All fundamentals and in-depth analysis of CardioComm Solutions

Our stock analysis for CardioComm Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CardioComm Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

CardioComm Solutions Stock
CardioComm Solutions Revenue→
CardioComm Solutions Stock
CardioComm Solutions Net Income→
CardioComm Solutions Stock
CardioComm Solutions P/E→
CardioComm Solutions Stock
CardioComm Solutions P/S→
CardioComm Solutions Stock
CardioComm Solutions EBIT→
CardioComm Solutions Stock
CardioComm Solutions Dividend→
CardioComm Solutions Stock
CardioComm Solutions Directors Dealings→
CardioComm Solutions Stock
CardioComm Solutions Stocks→
CardioComm Solutions Stock
CardioComm Solutions Market capitalization→
CardioComm Solutions Stock
CardioComm Solutions Debt→
CardioComm Solutions Stock
CardioComm Solutions Liabilities→
CardioComm Solutions Stock
CardioComm Solutions Equity→
CardioComm Solutions Stock
CardioComm Solutions AAQS→
CardioComm Solutions Stock
CardioComm Solutions Employees→
CardioComm Solutions Stock
CardioComm Solutions ROE→
CardioComm Solutions Stock
CardioComm Solutions ROA→
CardioComm Solutions Stock
CardioComm Solutions ROCE→
CardioComm Solutions Stock
CardioComm Solutions News→
CardioComm Solutions Stock
CardioComm Solutions Analyst Price Targets→

Health Stocks

CardioGenics HoldingsCardio Diagnostics HoldingsCardiol TherapeuticsCardinal HealthCare Service CoCardiff OncologyCare TwentyoneCardaxCareCloudCaptor CapitalCareDxCapstone HoldingAll Stocks A–Z →